Literature DB >> 30981885

Autophagy as a molecular target for cancer treatment.

Nur Mehpare Kocaturk1, Yunus Akkoc2, Cenk Kig3, Oznur Bayraktar4, Devrim Gozuacik5, Ozlem Kutlu6.   

Abstract

Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment. Recent findings revealed a close relationship between autophagy and malignant transformation. However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful. Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism. In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3-MethylAdenine(3-MA) (PubChem CID: 1673); 5-Fluorouracil (5-FU) (PubChem CID: 3385); Allicin (PubChem CID: 65036); Apatinib (PubChem CID: 45139106); Arsenic trioxide (As(2)O(3)) (PubChem CID: 14888); Autophagy; Bafilomycin A1 (PubChem CID: 6436223); Bortezomib (PubChem CID: 387447); Brefeldin A (PubChem CID: 5287620); Camptothecin (PubChem CID: 24360); Cancer; Chloroquine (PubChem CID: 64927); Cisplatin (PubChem CID: 5702198); Curcumin (PubChem CID: 969516); Diethylnitrosamine (DEN) (PubChem CID: 5921); Epigallocatechin gallate (EGCG) (PubChem CID: 65064); Erlotinib (PubChem CID: 176870); Everolimus (PubChem CIDL: 6442177); Gefitinib (PubChem CID: 123631); Ginsenoside F2 (PubChem CID: 9918692); Ginsenoside Rb1 (PubChem CID: 9898279); Hidroxychloroquine (PubChem CID: 3652); Imatinib (PubChem CID:5291); LY294002 (PubChem CID: 3973); Lapatinib (PubChem CID: 208908); Monensin (PubChem CID: 441145); NVP-BEZ235 (PubChem CID: 11977753); Polygonatum cyrtonema lectin (PCL) (PubChem SID: 103031201); Quinazolinediamine (QZN) (PubChem CID: 65087); Rapamycin (PubChem CID: 62969); Resveratrol (PubChem CID: 445154); Ridaforolimus (PubChem CID: 11520894); Romidepsin (PubChem CID: 5352062); SAR405 (PubChem CID: 72709209); Scutellarein (PubChem CID: 185617); Sertraline (PubChem CID: 68617); Sorafenib (PubChem CID: 216239); Spautin-1 (PubChem CID: 51037431); Spermidine (PubChem CID: 1102); Suberoylanilide Hydroxamic acid (SAHA) (PubChem CID: 5311); Tamoxifen (PubChem CID: 2733526); Temozolomide (PubChem CID: 5394); Temsirolimus (PubChem CID: 86277830); Therapeutic agents; Trastuzumab (PubChem CID: 96849); Vandetanib (PubChem CID: 3081361); Varinostat (PubChem CID: 5311); Vinblastine (PubChem CID: 13342); Viridiol (PubChem CID: 5459246); Wortmannin (PubChem CID: 312145)

Year:  2019        PMID: 30981885     DOI: 10.1016/j.ejps.2019.04.011

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  70 in total

Review 1.  Resveratrol as a modulatory of apoptosis and autophagy in cancer therapy.

Authors:  R Yang; H Dong; S Jia; Z Yang
Journal:  Clin Transl Oncol       Date:  2022-01-17       Impact factor: 3.405

Review 2.  Role of autophagy in drug resistance and regulation of osteosarcoma (Review).

Authors:  Yanchuan Pu; Jin Wang; Shizhong Wang
Journal:  Mol Clin Oncol       Date:  2022-02-01

3.  The dicyano compound induces autophagic or apoptotic cell death via Twist/c-Myc axis depending on metastatic characteristics of breast cancer cells.

Authors:  Ozge Alvur; Hakan Kucuksayan; Yasemin Baygu; Nilgun Kabay; Yasar Gok; Hakan Akca
Journal:  Mol Biol Rep       Date:  2021-11-13       Impact factor: 2.316

Review 4.  Autophagy and Hepatic Tumor Microenvironment Associated Dormancy.

Authors:  Yunus Akkoc; Devrim Gozuacik
Journal:  J Gastrointest Cancer       Date:  2021-12-18

5.  The regulatory effects of clomiphene and tamoxifen on mTOR and LC3-II expressions in relation to autophagy in experimental polycystic ovary syndrome (PCOS).

Authors:  Gökçe Ceren Kuşçu; Çevik Gürel; Aylin Buhur; Fatih Oltulu; Levent Akman; Timur Köse; Nefise Ülkü Karabay Yavaşoğlu; Altuğ Yavaşoğlu
Journal:  Mol Biol Rep       Date:  2021-11-23       Impact factor: 2.316

6.  Do Wortmannin and Thalidomide induce apoptosis by autophagy inhibition in 4T1 breast cancer cells in vitro and in vivo?

Authors:  Elgin Turkoz Uluer; Pinar Kilicaslan Sonmez; Damla Akogullari; Melike Onal; Gamze Tanriover; Sevinc Inan
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 7.  Recent developments in autophagy-targeted therapies in cancer.

Authors:  Manasi P Jogalekar; Anurag Veerabathini; Prakash Gangadaran
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-09

Review 8.  Autophagy and disease: unanswered questions.

Authors:  Ying Yang; Daniel J Klionsky
Journal:  Cell Death Differ       Date:  2020-01-03       Impact factor: 15.828

Review 9.  Recent Advances in Understanding the Role of Autophagy in Paediatric Brain Tumours.

Authors:  Francesca Gatto; Giacomo Milletti; Andrea Carai; Angela Mastronuzzi; Francesca Nazio
Journal:  Diagnostics (Basel)       Date:  2021-03-09

10.  Mechanism of Anticancer Action of Novel Imidazole Platinum(II) Complex Conjugated with G2 PAMAM-OH Dendrimer in Breast Cancer Cells.

Authors:  Robert Czarnomysy; Anna Muszyńska; Jakub Rok; Zuzanna Rzepka; Krzysztof Bielawski
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.